Relmada Therapeutics Inc
Relmada Therapeutics Inc (RLMD) Implied Volatility Current
RLMD implied volatility is 91%. IV Rank is 22%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking RLMD implied volatility helps you identify when options premiums on Relmada Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Relmada Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when RLMD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Relmada Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For RLMD, tracking metrics like RLMD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on RLMD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where RLMD implied volatility sits today versus where it has been. Our scanner ranks Relmada Therapeutics Inc implied volatility against its historical range, surfaces extremes in RLMD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Relmada Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track RLMD IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→